![Jörn Drappa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörn Drappa
Chief Tech/Sci/R&D Officer at
ALUMIS INC.
Net worth: 1 M $ as of 2026-05-30
Profile
Jörn Drappa was the founder of Viela Bio, Inc., founded in 2018, where the title held was Chief Medical Officer, Head-Research & Development from 2018 to 2021.
The current job is Chief Medical Officer at Alumis, Inc. starting in 2022.
Former jobs include Associate Director-Medical at Amgen, Inc. from 2003 to 2006; Senior Medical Director at Genentech, Inc. from 2008 to 2011; Vice President-Clinical Development at MedImmune LLC from 2011 to 2018; Executive Vice President-Research & Development at Horizon Therapeutics Ltd. (Ireland) in 2021; Chief Medical Officer at Ventyx Biosciences, Inc. from 2021 to 2022; and Director at Alpine Immune Sciences, Inc. from 2022 to 2024.
Education includes a doctorate from Universität zu Köln conferred in 1991 and a doctorate from Weill Cornell Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALUMIS INC. 0.05% | 2026-05-21 | 59,339 ( 0.05% ) | 1 M $ | 2026-05-30 |
Jörn Drappa active positions
| Companies | Position | Start |
|---|---|---|
| ALUMIS INC. | Chief Tech/Sci/R&D Officer | 2022-08-31 |
Former positions of Jörn Drappa
| Companies | Position | End |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Director/Board Member | 2024-05-19 |
| VENTYX BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-05-04 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 2021-08-31 |
| VIELA BIO, INC. | Founder | 2021-03-14 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Tech/Sci/R&D Officer | 2018-01-31 |
Training of Jörn Drappa
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
Weill Cornell Medicine
 Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
- Stock Market
- Insiders
- Jörn Drappa
